Francisco J. Estevez-Molina

Pts
Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A novel Dual-guide CRISPR-Cas13 strategy improves specificity for single-nucleotide variant detection.

A novel Dual-guide CRISPR-Cas13 strategy improves specificity for single-nucleotide variant detection.

Journal: Nucleic acids research

Published: August 13, 2025

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Journal: Frontiers in genome editing

Published: July 16, 2025

Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.

Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.

Journal: Molecular therapy. Nucleic acids

Published: February 24, 2025

Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation.

Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation.

Journal: Nucleic acids research

Published: August 12, 2024

Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome.

Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome.

Journal: Frontiers in immunology

Published: March 15, 2024

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.

Journal: Molecular therapy. Nucleic acids

Published: February 26, 2024

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells.

Journal: Molecular therapy. Nucleic acids

Published: October 03, 2022

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.

Journal: Frontiers in immunology

Published: August 04, 2022

Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies.

Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies.

Journal: International journal of molecular sciences

Published: May 09, 2022

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods.

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods.

Journal: Journal of visualized experiments : JoVE

Published: December 10, 2019

Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.

Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.

Journal: PloS one

Published: March 22, 2018

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

Journal: Scientific reports

Published: November 24, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026